Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Older Breast Cancer Survivor
100%
Thinking with
94%
Cancer Study
88%
Survivors
71%
Non-cancer
39%
Breast Cancer
34%
Chemotherapy
28%
Metastatic Breast Cancer
27%
Cognitive Function
27%
Physical Activity
21%
COVID-19
19%
Tumor
17%
Systemic Therapy
17%
Processing Speed
16%
Women with Breast Cancer
15%
Older Women
15%
Breast Cancer Survivors
15%
Quality of Life
15%
Attentional Processing
15%
Executive Function
15%
Cancer-associated
13%
Cognitive Decline
13%
Oncologists
13%
Sleep Disturbance
13%
Deficit Accumulation
13%
Genotype
13%
Well-being
12%
Speed Function
12%
Cognitive Performance
12%
Machine Learning
12%
Longitudinal Relationship
12%
Depressive Symptoms
11%
Adjuvant Therapy
11%
Endocrine Therapy
11%
Randomized Phase II Trial
11%
Nivolumab
11%
Triple-negative Breast Cancer
11%
Taxanes
11%
Capecitabine
11%
Functional Assessment of Cancer Therapy
10%
Perceived Cognitive Impairment
10%
Apolipoprotein E4 (APOE4)
10%
Cognitive Difficulties
10%
Older Survivors
9%
Circulating Tumor DNA (ctDNA)
9%
Treatment-related
9%
Immunoscore
9%
Early Breast Cancer
9%
Medicine and Dentistry
Breast Cancer
94%
Malignant Neoplasm
59%
Chemotherapy
27%
Hormone Therapy
26%
Cognition
20%
Systemic Therapy
14%
Oncologist
12%
Cognitive Decline
12%
COVID-19
11%
Quality of Life
11%
Triple Negative Breast Cancer
11%
Nivolumab
11%
Capecitabine
11%
Genetics
11%
Cancer Therapy
10%
Tumor
10%
Executive Function
10%
Physical Activity
9%
Recurrent Disease
9%
Functional Assessment
9%
Decision Making
8%
Diseases
7%
Comorbidity
7%
Gene Expression Profiling
7%
Cognitive Defect
7%
Oncology
6%
Neoplasm
6%
Biological Marker
6%
Arm
6%
Alzheimer's Disease
5%
Interleukin 6
5%
Health Care Cost
5%
Medical Care
5%
Adjuvant Therapy
5%
Retroperitoneum
5%
Breast Imaging
5%
Prostate Cancer
5%
Pooled Analysis
5%
Homologous Recombination
5%
Tumor Gene
5%
Next Generation Sequencing
5%
Single Nucleotide Polymorphism
5%
Real-World Evidence
5%
Isoprenaline
5%
Granulosa Cell Tumour
5%
Area Deprivation
5%
Metastatic Breast Cancer
5%